MedPath
NMPA Approval

Insulin Glargine Injection

国药准字S20050051

October 15, 2024

Drug Information

甘精胰岛素注射液

长秀霖

长秀霖

注射剂

3ml:300单位/支

生物制品

October 15, 2024

Company Information

Applicant Company

北京市通州区漷县镇南凤西一路8号

Manufacturing Company

北京市通州区漷县镇南凤西一路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甘精胰岛素注射液 - NMPA 批准文号 | MedPath